Analysts point to Definium psychedelic’s MDD efficacy on Phase III success
The rapid onset and durability of response triggered by DT120 could significantly benefit patients with MDD, say analysts and researchers.
23 June 2026
23 June 2026
The rapid onset and durability of response triggered by DT120 could significantly benefit patients with MDD, say analysts and researchers.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.